Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-05-22
2010-02-16
Yaen, Christopher H (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07662770
ABSTRACT:
Low molecular weight protein tyrosine phosphatase (LMW-PTP) is identified as a novel diagnostic and therapeutic target in cancer diagnosis, prognosis and treatment. The invention provides diagnostic and treatment methods useful in connection with cancers expressing LMW-PTP and, optionally, EphA2 receptor. Also provided is a screening method that utilizes changes in the amount and/or activity of LMW-PTP to identify candidate cancer therapeutic agents that effectively target the oncoprotein EphA2.
REFERENCES:
patent: 5876949 (1999-03-01), Dreyfuss et al.
patent: 5958957 (1999-09-01), Andersen et al.
patent: 6927203 (2005-08-01), Kinch et al.
patent: 7101976 (2006-09-01), Kilpatrick et al.
patent: 7192698 (2007-03-01), Kinch et al.
patent: 7479368 (2009-01-01), Brown et al.
patent: 7485420 (2009-02-01), Markowitz
patent: 7507418 (2009-03-01), Atkinson et al.
patent: 2004/0028685 (2004-02-01), Kinch et al.
patent: 2004/0091486 (2004-05-01), Kinch et al.
patent: 2005/0147593 (2005-07-01), Kinch
patent: 2005/0152899 (2005-07-01), Kinch et al.
patent: 2005/0153923 (2005-07-01), Kinch
patent: 2005/0169931 (2005-08-01), Kinch et al.
patent: 2006/0088541 (2006-04-01), Kinch et al.
patent: 2006/0093608 (2006-05-01), Kinch
patent: 2007/0086943 (2007-04-01), Kinch et al.
patent: 2008/0089931 (2008-04-01), Kinch
patent: 1242060 (2006-05-01), None
patent: 1695702 (2006-08-01), None
patent: WO 01/12172 (2001-02-01), None
patent: WO 01/12840 (2001-02-01), None
patent: WO 03/094859 (2003-11-01), None
patent: WO 03/099313 (2003-12-01), None
patent: WO 2004/014292 (2004-02-01), None
patent: WO 2004/014292 (2004-02-01), None
patent: WO 2005/051307 (2005-06-01), None
patent: WO 2005/051307 (2005-06-01), None
patent: WO 2005/055948 (2005-06-01), None
patent: WO 2005/055948 (2005-06-01), None
patent: WO 2005/056766 (2005-06-01), None
Carles-Kinch et al., “Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior,” May 15, 2002Cancer Research62(10):2840-2847.
Park et al., “Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway,” May 15, 2002Molecular and Cellular Biology22(10):3404-3414.
Souza et al., “From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase,” Apr. 2009Cellular and Molecular Life Sciences66(6):1140-1153. Available online on Nov. 11, 2008.
Supplementary European Search Report mailed Jun. 8, 2009, for EP Application No. 03734142.7 (3 pgs).
Cann, “Genetic clues to dispersal in human populations: retracting the past from the present,” Mar. 2, 2001Science291:1742-1748.
Garcia-Closas et al., “Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash,” Jun. 2001Cancer Epidemiology, Biomarkers&Prevention10:687-696.
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health. GenBank Locus NM—007099, Accession No. NM—007099, Version NM—007099.1 GI:6005987, “Homo sapiensacid phophatase 1, soluble (ACP1), transport variant b, mRNA,” [online]. Bethesda, MD [retrieved on Mar. 26, 2008]. Retrieved from the Internet: <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?6005987:OLD12:570167>; 3 pgs.
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, GenPept Locus P24666, Accession No. P24666, Version P24666 GI:1709543, “Red cell acid phosphatase 1, isoenzyme F (ACP1) (Low molecular weight phosphotyrosine phosphatase) (Adipocyte acid phosphatase, isoenzyme alpha),” [online]. Bethesda. MD [retrieved on Mar. 25, 2008]. Retrieved from the Internet: <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?1709543:OLD11:669086>; 4 pgs.
Åkerud et al., “Intramolecular Dynamics of Low Molecular Weight Protein Tyrosine Phosphatase in Monomer-Dimer Equilibrium Studied by NMR: A Model for Changes in Dynamics Upon Target Binding,”J. Mol. Biol., Sep. 6, 2002; 322(1):137-152.
Andres et al., “Expression of Two Noveleph-related Receptor Protein Tyrosine Kinases in Mammary Gland Development and Carcinogenesis,”Oncogene, May 1994;9:1461-1467.
Arakawa et al., “Genomic Organization of theKlebsiella pneumoniae cpsRegion Responsible for Serotype K2 Capsular Polysaccharide Synthesis in the Virulent Strain Chedid,”J. Bacteriol., Apr. 1995;177(7):1788-1796. Available online at Journal of Bacteriology [retrieved Oct. 25, 2006]. Retrieved from the Internet:<URL:http://jb.asm.org/cgi/reprint/177/7/1788>; 9 pgs.
Boivin et al., “The Human Red Cell Acid Phosphatase Is a Phosphotyrosine Protein Phosphatase Which Dephosphorylates the Membrane Protein Band 3,”Biochem. Biophys. Res. Commmun., Jan. 29, 1986;134(2):557-564.
Bugert et al., “Characterization of theams1 Gene Product as a Low Molecular Weight Acid Phosphatase Controlling Exopolysaccharide Synthesis ofErwinia amylovora,” FEBS Lett., Jan. 1997;400(2):252-256.
Brackenbury, “Control of Carcinoma Cell Motility by E-Cadherin,” Abstract and Final Report, Grant No. DAMD 17-98-1-8292; United States Army Medical Research and Material Command Grant, project dates Aug. 1, 1998 to Jul. 31, 2002 [retrieved on Jun. 7, 2007]. Retrieved from the Internet:<URL:http://stinet.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA409404>; 31 pgs.
Caselli et al., “The Inactivation Mechanism of Low Molecular Weight Phosphotyrosine-protein Phosphatase by H2O2,”J. Biol. Chem., Dec. 4, 1998; 273(49): 32554-32560. Available online at JBC Online [retrieved Oct. 25, 2006]. Retrieved from the Internet:<URL:http://www.jbc.org/cgi/reprint/273/49/32554>; 7 pgs.
Chernoff et al., “A Major Phosphotyrosyl-Protein Phosphatase from Bovine Heart is Associated with a Low-Molecular-Weight Acid Phosphatase,”Arch. Biochem. Biophys., Jul. 1985;240(1):135-145.
Chiaraugi et al., “The Src and Signal Transducers and Activators of Transcription Pathways As Specific Targets for Low Molecular Weight Phosphotyrosine-protein Phosphatase in Platelet-derived Growth Factor Signaling,”J. Biol. Chem., Mar. 20, 1998;273(12):6776-6785.
Clark et al., “Overexpression of the Ras-related TC21/R-Ras2 Protein May Contribute to the Development of Human Breast Cancers,”Oncogene, 1996 12(1):169-176.
Corden et al. “Low Molecular Weight Phosphatase,” Abstract, p. 20 of Project Detail, General Basic Research in the Walther Cancer Center of Excellence [online]. Walther Cancer Institute, Indianapolis, IN, project dates Jul. 1, 2004 to Jun. 30, 2005 [retrieved on Jun. 5, 2007]. Retrieved from the Internet:<URL:www.walther.org/wcf—scipro/wcf—projects/15.html>; 44 pgs.
Davis et al., “Kinetic and Site-directed Mutagenesis Studies of the Cysteine Residues of Bovine Low Molecular Weight Phosphotyrosyl Protein Phosphatase,”J. Biol. Chem., Mar. 25, 1994;269(12):8734-8740. Available online at JBC Online [retrieved Oct. 25, 2006]. Retrieved from the Internet:<URL:http://www.jbc.org/cgi/reprint/269/12/8734>; 7 pgs.
Dissing et al., “Human Red Cell Acid Phosphatase: Purification and Properties of the A, B, and C Isozymes,”Biochem. Biophys. Acta., Dec. 5, 1990;1041(3):232-242.
Easty et al., “Protein Tyrosine Kinases in Malignant Melanoma,”Melanoma Res., Oct. 2000;10(5):401-411.
Eph Nomenclature Committee, 1997, “Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins,”Cell, Aug. 8, 1997;90(3):403-404.
Fiaschi et al., “Low Molecular Weight Protein-tyrosine Phosphatase Is Involved in Growth Inhibition during Cell Differentiation,”J. Biol. Chem., Dec. 28, 2001;276(52):49156-49163; electronically published Oct. 10, 2001. Available online at JBC Online [retrieved Oct. 25, 2006]. Retrieved from the Internet:<URL:http:
Mueting Raasch & Gebhardt, P.A.
Purdue Research Foundation
Yaen Christopher H
LandOfFree
Low molecular weight protein tyrosine phosphatase (LMW-PTP)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low molecular weight protein tyrosine phosphatase (LMW-PTP)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low molecular weight protein tyrosine phosphatase (LMW-PTP)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152041